Tricida

Unlock to Claim this listing
Add / Modify Company

Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a chronic condition commonly caused by CKD that is believed to accelerate the progression of CKD, increase the risk of muscle wasting and cause the loss of bone density. Tricida has successfully completed all of the clinical trials that it planned to complete prior to submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), including a successful 135-subject, Phase 1/2 clinical trial (TRCA-101), a successful 217-subject, pivotal Phase 3 clinical trial (TRCA-301), and a successful 196-subject, Phase 3 extension trial (TRCA-301E). We plan to submit an NDA, in the second half of 2019, seeking approval of TRC101 through the FDA’s Accelerated Approval Program.

Click to rate this company
[Total: 0 Average: 0]

3.2

Overall Excellence Rating

Industry

Healthcare

Category

Biotech & Pharmaceuticals

ESG/Ethical Impact

Research and Development: Tricida’s focus on developing therapies could contribute to advancements in treating metabolic acidosis, potentially improving patient outcomes and reducing healthcare resource consumption. Regulatory Compliance: The company’s commitment to adhering to environmental regulations and guidelines ensures responsible operations in its research and manufacturing processes.Patient Health: Tricida’s therapies might significantly impact the health and well-being of patients with metabolic acidosis, improving their quality of life and long-term health prospects. Healthcare Access: The company’s efforts could result in improved access to effective treatments for individuals with metabolic acidosis, particularly those with chronic kidney disease.Leadership Structure: Tricida’s governance structure likely includes a leadership team responsible for strategic decisions and ethical practices. Ethical Clinical Trials: The company’s commitment to ethical clinical trials ensures patient safety and data integrity in the development of new therapies. Transparency: Tricida may emphasize transparent communication with patients, regulatory agencies, and the public about its research and development processes.Value Creation: Tricida’s ESG efforts could contribute to its long-term financial success by enhancing its reputation, attracting responsible investors, and improving operational efficiency. Innovation: The company’s commitment to developing innovative therapies might lead to breakthroughs in metabolic acidosis treatment and increased market value. Operational Efficiency: By implementing sustainable practices, Tricida may achieve cost savings through reduced resource consumption and streamlined operations.Investor Confidence: Strong ESG performance can attract investors who prioritize companies with responsible and ethical business practices.Patient Safety: Tricida’s focus on patient safety ensures that clinical trials and therapies meet rigorous standards for safety and efficacy. Regulatory Compliance: The company’s operations likely adhere to pharmaceutical regulations and ethical guidelines for research and development.

Eligible Awards

Coming Soon

Claim Your Award Badges

Do you work with Us

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received

2023

Revenues

$200,000,000.00

Website Traffic

Employee Rating

4.1

Customer Rating

3.8

Company Size

100-1000

ESG Risk Rating

3

We’re Happy to Help.

Do you have questions about your ranking, our projects, or why you’re not on the list?
Scroll to Top

Excellence In My Industry

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business in your specific industry – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best Practice Certified

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best of Best Practices

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the top 20 companies in your industry that has met the criteria for our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Newsweek Excellence 1000

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the Top 1000 companies that demonstrate excellence across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.